SCHEMBL27792152

SCHEMBL27792152

[N-]=[N+]=NC(=O)Cc1ccc(OCc2ccccc2)c2c1OCC(C=O)N2

nearest known ligand 0.31

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.31
CREBBP Q92793 1/20 0.31
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
POLB P06746 1/20 0.31
PTGER1 P34995 3/20 0.31
PTGER4 P35408 2/20 0.31
PTGER3 P43115 2/20 0.31
PTGER2 P43116 2/20 0.31
HPGD P15428 1/20 0.31
CCNB2 O95067 1/20 0.31
CDK1 P06493 1/20 0.31
CDK4 P11802 1/20 0.31
CCNB1 P14635 1/20 0.31
CCND1 P24385 1/20 0.31
CCNB3 Q8WWL7 1/20 0.31
S1PR5 Q9H228 1/20 0.31
CFD P00746 1/20 0.30
F11 P03951 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27815172 0.80 ALDH1A1 (0.33) BRD4CREBBPKDM4EALDH1A1L3MBTL1
SCHEMBL27770942 0.77 L3MBTL1 (0.46) BRD4CREBBPKDM4EALDH1A1L3MBTL1
SCHEMBL28801679 0.76 TDP1 (0.35) BRD4CREBBPKDM4EALDH1A1L3MBTL1
SCHEMBL27792032 0.76 MEN1 (0.36) BRD4CREBBPKDM4EALDH1A1L3MBTL1
SCHEMBL28411992 0.63 MAOB (0.45) CREBBPALDH1A1L3MBTL1MAPTFFAR1
SCHEMBL28992050 0.62 MEN1 (0.37) CREBBPS1PR5FFAR1
SCHEMBL28991825 0.62 MEN1 (0.37) CREBBPALDH1A1HPGDS1PR5FFAR1
SCHEMBL11354689 0.61 PTGER1 (0.47) BRD4PTGER1PTGER4PTGER3PTGER2
SCHEMBL28469694 0.61 CES1 (0.50) ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL13437541 0.59 BRD4 (0.35) BRD4CREBBPKDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101636379-A Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases ASTRAZENECA AB 2010-01-27 CN disclosed